Mehmet Sinan Dal

The outcome of COVID‐19 in patients with hematological malignancy

Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş et al. · Journal of Medical Virology · 2020 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Intensive Care Unit +15

Increased Caspase-3 Immunoreactivity of Erythrocytes in STZ Diabetic Rats

Uğur Fırat, Savaş Kaya, Abdullah Çim et al. · Experimental Diabetes Research · 2012 · 65 citations · Full text

Apoptosis, Blood Cell, Cell Death +18

Convalescent plasma therapy in patients with COVID-19

Fevzi Altuntaş, Naim Ata, Tuğçe Nur Yiğenoğlu et al. · Transfusion and Apheresis Science · 2020 · 65 citations · Full text

Covid-19 Pandemic, Convalescent Plasma Therapy, Covid-19 Epidemiology +3

Pesg PNH diagnosis, follow-up and treatment guidelines.

Fahri Şahin, Olga Meltem Akay, Mesut Ayer et al. · PubMed · 2016 · 49 citations · Full text

Disease Diagnosis, Urology, Study Group +14

Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Semih Başçı, Naim Ata, Fevzi Altuntaş et al. · Journal of Oncology Pharmacy Practice · 2020 · 40 citations · Full text